April 18, 2013 |
When a friend gets rich and famous and moves to Paris, then prattles on about the nutty things that French dentists say, that's grounds for never speaking to that person again. When the friend in question is an imaginary friend and his name is David Sedaris, such indiscretions are not only forgiven but embraced wholeheartedly. If there's ever been an author who is consistently forgiven for his trespasses, it's David Sedaris. In "Let's Explore Diabetes With Owls," everyone's favorite imaginary friend has abandoned France for the English countryside, where his life of leisure is only occasionally interrupted by sojourns to China, Australia and Japan.
April 13, 2013 |
The patient in his 50s was mildly overweight, had high cholesterol and was headed down the road to diabetes. Common problems, and his doctor made the usual recommendation: medications. But the patient, Michael Mosley - a British author, journalist, TV personality and doctor himself - decided to go a different route. He traveled around his own country and ours, interviewing leading researchers, then tested some of their latest findings. The result? "The Fast Diet," a bestselling book in Britain (it has nothing to do with fast food, how fast you eat or even how fast you lose weight)
CALIFORNIA | LOCAL
March 22, 2013 |
Los Angeles mayoral candidates Wendy Greuel and Eric Garcetti have traded bitter campaign attacks for months. At an annual fundraiser for diabetes research Thursday night, they traded jokes. The rivals took the stage at the Los Angeles Political Roast, which brought hundreds of elected leaders, lobbyists and other City Hall power players to the Beverly Hilton to have fun with serious issues like low voter turnout and the city's financial crisis. Their target this year was Councilman Tom LaBonge, who was ribbed for his love of television cameras and his rather ample waist size.
March 15, 2013 |
The Food and Drug Administration has announced that it will investigate whether a new class of Type 2 diabetes drugs sometimes called the "gliptins" may increase patients' risk of developing precancerous changes in the pancreas, as well as of developing acute pancreatitis. The drugs now under closer FDA scrutiny are called incretin mimetics and include such widely prescribed medications as the drug exenitide (marketed as Byetta and Bydureon), liraglutide (Victoza), sitagliptin (Januvia and Janumet or Juvisync)
March 7, 2013 |
Scientists hoping to mimic the life-extending qualities produced by a chemical found in red wine and dark chocolate say they have solved one of the mysteries about how this compound works to combat the effects of obesity, diabetes, certain cancers and a host of other maladies. The findings, published in Friday's edition of the journal Science, could lay the foundation for a variety of drugs that act like concentrated amounts of resveratrol, the compound that has inspired a $30-million-a-year supplement business.
February 27, 2013 |
In a finding certain to put new pressure on the purveyors of sugary foods and drinks, a worldwide analysis shows that regardless of its effect on obesity, the ebb and flow of sugar in a country's diet strongly influences the diabetes rate there. The new study provides compelling evidence that obesity isn't driving the worldwide pandemic of Type 2 diabetes as much as the rising consumption of sugar - largely in the form of sweetened sodas, experts said. Increases in sugar intake account for a third of new cases of diabetes in the United States and a quarter of cases worldwide, according to calculations published Wednesday in the journal PLOS ONE. In the 175 countries studied, a 150-calorie daily increase in the availability of sugar - about the equivalent of a can of Coke or Pepsi - raises the prevalence of Type 2 diabetes by 1.1%, a research team from Stanford University and UC San Francisco found.
January 18, 2013 |
Why are women more prone to autoimmune diseases like lupus, multiple sclerosis and rheumatoid arthritis? A new study in mice points to a possible contributor: different types of bacteria that populate our guts. It goes like this: Different mixes of bacteria reside in the innards of male and female mice. Those bacteria, in turn, affect the chemistry of the animals' bodies -- and, it appears, their risk of autoimmunity. The study, just published in Science , was done by Janet Markle of the Hospital for Sick Children Research Institute, Toronto, and colleagues. It's a little complicated, with players that include sex hormones, fatty chemicals, immune cells and a whole host of microscopic life forms.
January 12, 2013
Re "Diabetes a stubborn foe," Jan. 6 Though the article successfully portrayed indifferent diabetics, it neglected to mention the uncommon diabetics who work out and eat right. I am an 18-year-old diabetic, and while I can attest that diabetes is a terrible illness, most of its consequences can be avoided by putting down the potato chips and picking up a dumbbell. Unfortunately, in this day and age, something so simple is controversial. Eric Herschler Garden Grove Diabetes patients who store candy next to their insulin should be starkly confronted with the very real possibility of death from the disease.
January 9, 2013 |
After all those well-intentioned New Year's resolutions have yielded to the force of habit, many of the nation's 79 million obese adults will have a day of reckoning with their primary care physicians. Lose weight and get active, the doctor will order, or risk developing diabetes. Then the MD will scribble a prescription. For most patients, the prescribed treatment will not be a pill. It will be a 12-week program aimed at preventing Type 2 diabetes by getting obese adults to shed as little as 10 pounds and exercise for a little more than 20 minutes a day. That regimen -- the Diabetes Prevention Program -- may soon become the blockbuster prescription medicine you've never heard of. In 2013, it is poised to become the envy of pharmaceutical companies, a new rival to programs such as Weight Watchers, and a target of opportunity for healthcare entrepreneurs.
CALIFORNIA | LOCAL
January 6, 2013 |
One by one, the diabetic patients reluctantly stepped on the scale in the basement of a South Los Angeles clinic. Nearby, a nurse scribbled numbers on a chart. Camara January, 31, her round face framed by a sparkly headband, held her breath. The number stopped at 245 pounds. "That's not good," January said. Tracy Donald, 45, stepped up. Just under 240 pounds. "That is wrong," she said. Ramon Marquez, 62, tall and clean-shaven, methodically took off his watch, his cap and his shoes.